Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
rose flower
- Development stage
- Preclinical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Rose flower refers to the bloom of the *Rosa* genus, including species like *Rosa hybrida* and *Rosa chinensis*. Extracts from rose flowers are being investigated for various biological activities, including the inhibition of α-glucosidase by polyphenol-rich extracts, and antimicrobial and anticancer effects demonstrated by acetone extracts. The flower is also recognized for its antioxidant properties, attributed to its content of polyphenols, flavonoids, and anthocyanins. It is utilized in edible products and as a source for extracts with potential health-promoting benefits.
- Other names
- 玫瑰花
02
Targets
Sucrase-IsomaltasePGN (Peptidoglycan)
Beyond the preview
Go deeper on rose flower.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on rose flower.